Startup building ‘biowearables’ for chronic kidney disease nets €2.3M
Chronic kidney disease (CKD) affects10% of the populationand is thethird fastest-growing cause of deathworldwide. Its also associated with a heavy financial impact on healthcare, with its treatment costing the EU140bnper year. It’s free, every week, in your inbox. CKD is one of the major chronic diseases in terms of prevalence, mortality and cost. The medtech startup will first targetend-stage patients with hyperkalemia issues and extend its scope down to earlier stage patients....